---
trial_id: 756
discovery_date: 2022-04-25 18:10:07.659626
date: 2022-04-25 18:10:07.659626
title: "Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Tolerability, and Efficacy of BIIB092 in Subjects with Mild Cognitive Impairment due to Alzheimer’s Disease ..."
summary: |
  <p>EudraCT Number: 2017-002901-37<br />Sponsor Protocol Number: 251AD201<br />Sponsor Name: Biogen Idec Research Limited<br />Start Date: 2018-06-04<br />Medical condition: Mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) or mild AD<br />Disease: <br />Version: 20.0<br />SOC Term: 100000004852<br />Classification Code: 10001896<br />Term: Alzheimer's disease<br />Level: LLT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002901-37/DE">DE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002901-37/SE">SE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002901-37/ES">ES</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002901-37/IT">IT</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002901-37/PL">PL</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002901-37/FR">FR</a> (Prematurely Ended)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002901-37'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2017-002901-37<br />Sponsor Protocol Number: 251AD201<br />Sponsor Name: Biogen Idec Research Limited<br />Start Date: 2018-06-04<br />Medical condition: Mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) or mild AD<br />Disease: <br />Version: 20.0<br />SOC Term: 100000004852<br />Classification Code: 10001896<br />Term: Alzheimer's disease<br />Level: LLT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002901-37/DE">DE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002901-37/SE">SE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002901-37/ES">ES</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002901-37/IT">IT</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002901-37/PL">PL</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002901-37/FR">FR</a> (Prematurely Ended)</p>